Tone mix
Week by week 52 weeks
Share of argenx SE American Depositary Shares's 268 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Oct 5, 2026 · tone -3210 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?-96
- Week of Nov 24, 2025 · tone -33Handelsbanken Fonder AB Buys 1,703 Shares of argenex SE $ARGX-78
- Week of Dec 15, 2025 · tone -37Research Analysts' Price Target Changes for December 17th (AAMI, ADC, ADT, ADV, AMAT, ANET, ARGX, ARMK, ARWR, BAC)-70
- Week of Oct 12, 2026 · tone -25argenex (NASDAQ:ARGX) Stock Gets Price Target Reduction from Robert W. Baird-68
- Week of Jan 12, 2026 · tone +77argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG+61
- Week of Jun 1, 2026 · tone +100Argenx Reports Positive Efgartigimod Data In Myositis And Sjogren's Disease+58
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about argenx SE American Depositary Shares in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 15 | +12 |
| Last 30 sessions | 33 | +6 |
| Last 90 sessions | 112 | +51 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.dailypolitical.com · 2 outletsargenex (NASDAQ:ARGX) Stock Rating Lowered by Wall Street ZenNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| argenex (NASDAQ:ARGX) Stock Rating Lowered by Wall Street Zen | www.dailypolitical.com | 2 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
6 headlines, average tone +31: 3 positive, 2 neutral and 1 negative. Showing all 6.
- www.tickerreport.com · 1 outletargenx (NASDAQ: ARGX) net sales jump 54% as pipeline milestones stack upPositive
- www.themarketsdaily.com · 1 outletWells Fargo & Company Has Lowered Expectations for argenex (NASDAQ:ARGX) Stock PriceNegative
- www.themarketsdaily.com · 1 outletargenex (NASDAQ:ARGX) Issues Earnings Results, Beats Estimates By $0.36 EPSPositive
- econotimes.com · 1 outletargenx Eyes Up to Five Potential U.S. Launches for 2027Positive
- www.tickerreport.com · 1 outletStock Analysts' Price Target Changes for October 23rd (AAL, AAP, ADP, AFRM, AGNC, AJB, ALLE, AOSL, ARGX, ARR)Neutral
- www.dailypolitical.com · 1 outletargenex (NASDAQ:ARGX) Issues Quarterly Earnings ResultsNeutral
Show the table · 6 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| argenx (NASDAQ: ARGX) net sales jump 54% as pipeline milestones stack up | www.tickerreport.com | 1 | Positive |
| Wells Fargo & Company Has Lowered Expectations for argenex (NASDAQ:ARGX) Stock Price | www.themarketsdaily.com | 1 | Negative |
| argenex (NASDAQ:ARGX) Issues Earnings Results, Beats Estimates By $0.36 EPS | www.themarketsdaily.com | 1 | Positive |
| argenx Eyes Up to Five Potential U.S. Launches for 2027 | econotimes.com | 1 | Positive |
| Stock Analysts' Price Target Changes for October 23rd (AAL, AAP, ADP, AFRM, AGNC, AJB, ALLE, AOSL, ARGX, ARR) | www.tickerreport.com | 1 | Neutral |
| argenex (NASDAQ:ARGX) Issues Quarterly Earnings Results | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
5 headlines, average tone -20: 1 positive, 2 neutral and 2 negative. Showing all 5.
- www.investors.com · 1 outletArgenx Stock Slumps On Mixed Third Quarter, Surprise Vyvgart Testing PlansNegative
- www.dailypolitical.com · 1 outletargenx (NASDAQ: ARGX) net sales jump 54% as pipeline milestones stack upPositive
- www.investors.com · 1 outletArgenx Stock Wavers After A Surprise Testing Setback For Its Bread-And-Butter DrugNegative
- www.fool.com · 1 outletargenx: 3 Key Takeaways for Long-Term InvestorsNeutral
- www.fool.com · 1 outletargenx (ARGX) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Argenx Stock Slumps On Mixed Third Quarter, Surprise Vyvgart Testing Plans | www.investors.com | 1 | Negative |
| argenx (NASDAQ: ARGX) net sales jump 54% as pipeline milestones stack up | www.dailypolitical.com | 1 | Positive |
| Argenx Stock Wavers After A Surprise Testing Setback For Its Bread-And-Butter Drug | www.investors.com | 1 | Negative |
| argenx: 3 Key Takeaways for Long-Term Investors | www.fool.com | 1 | Neutral |
| argenx (ARGX) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
3 headlines, average tone +66: 2 positive, 1 neutral and 0 negative. Showing all 3.
- ksevradio.com · 1 outletArgenx says Vyvgart sales rose 54% in third quarterPositive
- 247wallst.com · 1 outletargenx Q3 2026: $1.72B Revenue and Five 2027 Launches AheadPositive
- www.manilatimes.net · 1 outletargenx Reports Third Quarter 2026 Financial Results and Provides Business UpdateNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Argenx says Vyvgart sales rose 54% in third quarter | ksevradio.com | 1 | Positive |
| argenx Q3 2026: $1.72B Revenue and Five 2027 Launches Ahead | 247wallst.com | 1 | Positive |
| argenx Reports Third Quarter 2026 Financial Results and Provides Business Update | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletargenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026 | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about argenx SE American Depositary Shares, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.